Table 1.
Cumulative clinical data of COVID-19 patients.
| COVID-19 patients | Mild (n = 3) | Moderate (n = 14) | Severe (n = 18) |
|---|---|---|---|
| Demographic and clinical data | |||
| Age, years median ± SD | 78 ± 6.48 | 52.5 ± 10.59 | 65 ± 13.31 |
| Sex, M/F | 0/3 | 9/5 | 14/4 |
| Intensive/high care admission (%) | 0% | 7% | 83% |
| Deceased within 33 d of admission | 0/3 | 0/14 | 6/18 |
| Peripheral blood laboratory parameters median ± SD | |||
| Leukocyte count × 109/Liters | 6.36 ± 1.4 | 6.74 ± 3.7 | 8.69 ± 5 |
| Neutrophil count × 109/Liters | 4.59 ± 0.89 | 4.79 ± 3.1 | 7.35 ± 4.79 |
| Lymphocyte count × 109/Liters | 1.22 ± 0.42 | 1.09 ± 0.47 | 0.95 ± 0.49 |
| Neutrophil-to-lymphocyte ratio | 3.76 ± 1.22 | 5.02 ± 4.27 | 5.91 ± 8.03 |
| Serum D-dimer | a | 0.59 ± 6.03 | 0.56 ± 0.12 |
| Serum CRP (mg/dl) | 42 ± 91.68 | 62.5 ± 45.3 | 131 ± 109.4 |
| Comorbidities | |||
| Diabetes | 1/3 | 3/14 | 3/18 |
| Heart disease | 2/3 | 1/14 | 6/18 |
| Chronic kidney disease | 1/3 | 0/14 | 0/18 |
| Sample timeline median ± SD | |||
| Days since symptom onset | b | 9.5 ± 4.45 | 14 ± 5.07 |
| Days since hospitalisation | 5 ± 5.1 | 2 ± 1.87 | 5.5 ± 4.07 |
a
Data not available.
b
Patients did not report a symptom onset date.
Statistical analysis was performed as follows: leukocyte count, neutrophil count, lymphocyte count, neutrophil-to-lymphocyte count, D-dimer, and CRP were analysed by one-way ANOVA with Tukey’s multiple comparisons. No parameter tested was significant.